Picture of Medtronic logo

MDT Medtronic News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic, Inc. <Origin Href="QuoteRef">MDT.N</Origin>

RNS Number : 6228W
BlackRock Group
10 November 2014

Ap19

FORM8.3

IRISHTAKEOVERPANEL

DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013

DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE

1. KEYINFORMATION

Nameofpersondealing(Note1)

BlackRock, Inc.

Companydealtin

Medtronic, Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)

$0.10 common shares

Dateofdealing

07 November 2014

2. INTERESTSANDSHORTPOSITIONS

(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)


Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities

60,409,915 (6.14%)

33,554 (0.00%)

(2)Derivatives(otherthanoptions)

973 (0.00%)

6,913 (0.00%)

(3)Optionsandagreementstopurchase/sell

0 (0.00%)

Total

60,410,888 (6.14%)

109,867 (0.01%)

(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)

Classofrelevantsecurity:

Long

Short


Number


(%)

Number


(%)

(1)Relevantsecurities



(2)Derivatives(otherthanoptions)



(3)Optionsandagreementstopurchase/sell



Total




Ap20

1. DEALINGS(Note4)

(a) Purchasesandsales

Purchase/sale

Numberofrelevantsecurities

Priceperunit(Note5)

Purchase

7,020

USD 68.1000

Purchase

26,300

USD 68.4034

Purchase

2,819

USD 68.4231

Purchase

15

USD 68.5500

Purchase

6,773

USD 68.6568

Sale

23,000

USD 67.9900

Sale

53,953

USD 68.5409

Please note: there was also a Transfer In of 5,442 Shares.

(b) Derivativestransactions(otherthanoptionstransactions)

Productname,

e.g.CFD

Natureoftransaction

(Note6)

Numberofrelevantsecurities

(Note7)

Priceperunit

(Note5)

CFD

Reducing Short

3,477

USD 67.9725

(c) Optionstransactionsinrespectofexistingrelevantsecurities

(i) Writing,selling,purchasingorvarying

Productname,

e.g.calloption

Writing,selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates(Note7)

Exercise price

Type,e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit(Note5)

Call Option

Sell Open

21,200

USD 70.00

American

05-Dec-14

USD 0.8499

Call Option

Buy Close

21,100

USD 65.50

American

07-Nov-14

USD 2.9377

(ii) Exercising

Productname,

e.g.calloption

Numberofsecurities

Exercisepriceper unit(Note5)




(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)

Natureoftransaction

(Note8)

Details

Priceperunit

(if applicable) (Note 5)





Ap21

2. OTHERINFORMATION

Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives

Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofany
relevantsecuritiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this
shouldbestated.

None

IsaSupplementalForm8attached?(Note9) YES

Dateofdisclosure

10 November 2014

Contactname

Gareth Slade

Telephonenumber

+44 207 743 2536

IfaconnectedEFM,nameofofferee/offerorwithwhichconnected


IfaconnectedEFM,statenatureofconnection(Note10)




Ap23

SUPPLEMENTALFORM8

IRISHTAKEOVERPANEL

DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013

DETAILSOFOPENPOSITIONS

(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)

OPENPOSITIONS(Note1)

Productname,

e.g.calloption

Written,orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price(Note2)

Type,e.g.American,Europeanetc.

Expiry date

Call option

Written

12,500

USD 66.000

American

14/11/2014

Call option

Written

35,700

USD 66.50

American

14/11/2014

Call option

Written

21,200

USD 70.00

American

05/12/2014

Notes

1.Wherethereareopenoptionpositionsoropenderivativepositions(exceptforCFDs),fulldetails
shouldbegiven.Fulldetailsofanyexistingagreementstopurchaseortosellmust alsobegivenonthisform.

2. Forallpricesandothermonetaryamounts,thecurrencymust bestated.

Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.


This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEURVSRSKAAAAA

Recent news on Medtronic

See all news